Twitter @juangangel Apitoxin, or honey bee venom, is a bitter colourless liquid; its active portion a mixture of proteins, which causes local inflammation and acts as an anticoagulant. A honeybee can inject 0.1 mg of venom via its stinger. It may have similarities to sea nettle toxin. The more modern study of apitherapy, specifically bee venom, was initiated through the efforts of Austrian physician Phillip Terc in his published results "Report about a Peculiar Connection Between the Bee stings and Rheumatism" in 1888. More recent popularity can be drawn to Charles Mraz (1905–1999), a beekeeper from Vermont, United States over the past 60 years.[3] Health claims Apitherapy is widely promoted as having a wide range of health benefits, including the ability to treat multiple sclerosis, to alleviate various types of pain, and to boost general wellbeing.[2] Such claims are not supported by medical evidence.[2] Although honey and its derivative products are under investigation for possible medical applications in cancer therapy there are, according to the American Cancer Society, "no clinical studies in humans showing that bee venom or other honeybee products are effective in preventing or treating cancer Source https://en.wikipedia.org/wiki/Apitoxin Juan Gonzalo Angel www.tvagro.tv
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Trump $82 Million Bond Spree, Brazil Tariffs 'Too High,' More
16 Nov 2025
Bloomberg News Now
Ex-Fed Gov Resigned After Rules Violations, Trump Buys $82 Mil of Bonds, More
16 Nov 2025
Bloomberg News Now
THIS TRUMP INTERVIEW WAS INSANE!
16 Nov 2025
HasanAbi
Epstein Emails and Trump's Alleged Involvement
15 Nov 2025
Conspiracy Theories Exploring The Unseen
New Epstein Emails Directly Implicate Trump - H3 Show #211
15 Nov 2025
H3 Podcast
Trump Humiliates Himself on FOX as They Call Him Out
15 Nov 2025
IHIP News